Management of hydrocephalus in pediatric metastatic tumors of the posterior fossa at presentation

Management of hydrocephalus in pediatric metastatic tumors of the posterior fossa at presentation Childs Nerv Syst (2017) 33:1473–1480 DOI 10.1007/s00381-017-3447-5 ORIGINAL PAPER Management of hydrocephalus in pediatric metastatic tumors of the posterior fossa at presentation 1 1 2 3 Luc Le Fournier & Matthieu Delion & Maxime Esvan & Emilie De Carli & 4 1 1 5,6 Céline Chappé & Philippe Mercier & Philippe Menei & Laurent Riffaud Received: 22 February 2017 /Accepted: 1 May 2017 /Published online: 11 May 2017 Springer-Verlag Berlin Heidelberg 2017 Abstract PVD group were reoperated after an average time of 53 days. Purpose Presence of metastases in newly diagnosed pediatric Specific oncologic treatment was initiated earlier in the VPS posterior fossa tumors (PFT) is not a rare situation, but optimal group (11 days) compared to ETV (27 days) and PVD treatment of associated hydrocephalus in these children has (23 days) groups. remained undetermined. Conclusions ETV should be avoided in cases of multiple Methods Twenty-nine children treated between January 2005 macroscopic metastases, and children who underwent ETV and December 2015 for a metastatic PFT associated with hy- must be followed carefully when metastatic cells are present drocephalus constituted the study cohort. Patients were divid- in CSF after tumor surgery. External ventricular drainage be- ed into three groups: ventriculoperitoneal http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Child's Nervous System Springer Journals

Management of hydrocephalus in pediatric metastatic tumors of the posterior fossa at presentation

Management of hydrocephalus in pediatric metastatic tumors of the posterior fossa at presentation

Childs Nerv Syst (2017) 33:1473–1480 DOI 10.1007/s00381-017-3447-5 ORIGINAL PAPER Management of hydrocephalus in pediatric metastatic tumors of the posterior fossa at presentation 1 1 2 3 Luc Le Fournier & Matthieu Delion & Maxime Esvan & Emilie De Carli & 4 1 1 5,6 Céline Chappé & Philippe Mercier & Philippe Menei & Laurent Riffaud Received: 22 February 2017 /Accepted: 1 May 2017 /Published online: 11 May 2017 Springer-Verlag Berlin Heidelberg 2017 Abstract PVD group were reoperated after an average time of 53 days. Purpose Presence of metastases in newly diagnosed pediatric Specific oncologic treatment was initiated earlier in the VPS posterior fossa tumors (PFT) is not a rare situation, but optimal group (11 days) compared to ETV (27 days) and PVD treatment of associated hydrocephalus in these children has (23 days) groups. remained undetermined. Conclusions ETV should be avoided in cases of multiple Methods Twenty-nine children treated between January 2005 macroscopic metastases, and children who underwent ETV and December 2015 for a metastatic PFT associated with hy- must be followed carefully when metastatic cells are present drocephalus constituted the study cohort. Patients were divid- in CSF after tumor surgery. External ventricular drainage be- ed into three groups: ventriculoperitoneal shunt (VPS), endo- fore or during surgical removal should not be considered as a scopic third ventriculostomy (ETV), and temporary ventricu- final option to treat hydrocephalus. VPS remains a safe alter- lar drainage before or during tumor resection (PVD). native in this situation and allows an early specific oncologic Results There were 4 VPS, 18 ETV, and 7 PVD. The global treatment. incidence of CSF diversion failure was 52%. No case of dys- function or dissemination of metastatic cells occurred in the . Keywords Posterior fossa tumors metastases VPS group. Recurrence of hydrocephalus occurred in 55% of...
Loading next page...
 
/lp/springer_journal/management-of-hydrocephalus-in-pediatric-metastatic-tumors-of-the-gXYqWsoEno
Publisher
Springer Berlin Heidelberg
Copyright
Copyright © 2017 by Springer-Verlag Berlin Heidelberg
Subject
Medicine & Public Health; Neurosurgery; Neurosciences
ISSN
0256-7040
eISSN
1433-0350
D.O.I.
10.1007/s00381-017-3447-5
Publisher site
See Article on Publisher Site

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Unlimited reading

Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.

Stay up to date

Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.

Organize your research

It’s easy to organize your research with our built-in tools.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

Monthly Plan

  • Read unlimited articles
  • Personalized recommendations
  • No expiration
  • Print 20 pages per month
  • 20% off on PDF purchases
  • Organize your research
  • Get updates on your journals and topic searches

$49/month

Start Free Trial

14-day Free Trial

Best Deal — 39% off

Annual Plan

  • All the features of the Professional Plan, but for 39% off!
  • Billed annually
  • No expiration
  • For the normal price of 10 articles elsewhere, you get one full year of unlimited access to articles.

$588

$360/year

billed annually
Start Free Trial

14-day Free Trial